Allergy:早发特应性皮炎的恶化与儿童气源过敏原致敏和过敏性鼻炎的发生有关么?

2021-10-11 AlexYang MedSci原创

调查了早发的重度特应性皮炎(AD)与气源性过敏原致敏和过敏性鼻炎的关系。

因皮肤屏障缺陷导致过敏原接触,是诱发致敏和过敏性疾病发展的一种机制。

近期,来自丹麦的研究人员在《Allergy》上发表文章,他们假设早发的重度特应性皮炎(AD)与气源性过敏原致敏和过敏性鼻炎的发展有关

研究人员从哥本哈根儿童哮喘前瞻性研究2000(COPSAC2000)中纳入了368名儿童。根据Hanifin&Rajka标准对AD进行了前瞻性诊断,并使用特应性皮炎评分(SCORAD)指数评估了严重程度。早发AD定义为首次发病≤1岁,晚期发病为首次发病时1-6岁。气源性过敏原致敏和过敏性鼻炎在6-7岁和12岁时诊断。还使用一般估计方程(GEE)模型推算了早发和晚发AD与过敏之间的关系,并计算了早发和晚发两个时间点的几率(OR)。

结果发现,早发AD和严重程度(SCORAD)与儿童气源性过敏原致敏的发展有关,GEE分别为OR=1.68 [1.08; 2.62], p=0.02和1.08 [1.03; 1.12], p<0.001;而晚发AD显示出与儿童气源性过敏原致敏存在边缘性显著关联,严重程度则没有关联,GEE分别为OR=1.65 [0.92; 2.94], p=0.08和1.01 [0.97; 1.06], p=0.55。过敏性鼻炎与气源性过敏原致敏有同样的趋势,即早发AD与过敏性鼻炎之间存在显著的关联,GEE OR=1.56 [1.01; 2.41], p =0.04;严重程度,GEE OR=1.09 [1.05; 1.13], p<0.001;晚发AD与过敏性鼻炎没有关联。另外,早期发病与晚期发病的AD严重程度对气源性致敏和过敏性鼻炎的影响明显不同:致敏:p-interaction=0.03;鼻炎:p-interaction<0.01。

早发AD和晚发AD与过敏性鼻炎的相关性情况

综上所述,早发AD以及严重程度与儿童气源性过敏原致敏和过敏性鼻炎有关

原始出处:

Ann-Marie Malby Schoos , Bo Lund Chawes , Klaus Bønnelykke et al. Increasing severity of early-onset atopic dermatitis, but not late-onset, associates with development of aeroallergen sensitization and allergic rhinitis in childhood. Allergy. Sep 2021

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1664127, encodeId=ff5f166412e22, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Apr 06 06:56:52 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194477, encodeId=508f11944e72b, content=很棒,皮肤、呼吸、消化道过敏等是否都有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f526507984, createdName=ms3000000617950584, createdTime=Thu Feb 17 16:04:54 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047449, encodeId=4426204e4495b, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jul 15 11:56:52 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329563, encodeId=58a113295636c, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442648, encodeId=c1ff144264863, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1664127, encodeId=ff5f166412e22, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Apr 06 06:56:52 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194477, encodeId=508f11944e72b, content=很棒,皮肤、呼吸、消化道过敏等是否都有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f526507984, createdName=ms3000000617950584, createdTime=Thu Feb 17 16:04:54 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047449, encodeId=4426204e4495b, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jul 15 11:56:52 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329563, encodeId=58a113295636c, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442648, encodeId=c1ff144264863, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=)]
    2022-02-17 ms3000000617950584

    很棒,皮肤、呼吸、消化道过敏等是否都有相关性

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1664127, encodeId=ff5f166412e22, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Apr 06 06:56:52 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194477, encodeId=508f11944e72b, content=很棒,皮肤、呼吸、消化道过敏等是否都有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f526507984, createdName=ms3000000617950584, createdTime=Thu Feb 17 16:04:54 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047449, encodeId=4426204e4495b, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jul 15 11:56:52 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329563, encodeId=58a113295636c, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442648, encodeId=c1ff144264863, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1664127, encodeId=ff5f166412e22, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Apr 06 06:56:52 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194477, encodeId=508f11944e72b, content=很棒,皮肤、呼吸、消化道过敏等是否都有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f526507984, createdName=ms3000000617950584, createdTime=Thu Feb 17 16:04:54 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047449, encodeId=4426204e4495b, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jul 15 11:56:52 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329563, encodeId=58a113295636c, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442648, encodeId=c1ff144264863, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=)]
    2021-10-12 膀胱癌
  5. [GetPortalCommentsPageByObjectIdResponse(id=1664127, encodeId=ff5f166412e22, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Apr 06 06:56:52 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194477, encodeId=508f11944e72b, content=很棒,皮肤、呼吸、消化道过敏等是否都有相关性, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f526507984, createdName=ms3000000617950584, createdTime=Thu Feb 17 16:04:54 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047449, encodeId=4426204e4495b, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jul 15 11:56:52 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329563, encodeId=58a113295636c, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442648, encodeId=c1ff144264863, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Tue Oct 12 11:56:52 CST 2021, time=2021-10-12, status=1, ipAttribution=)]

相关资讯

Eur Arch Otorhinolaryngol:透明质酸钠能否减轻过敏性鼻炎患者的鼻症状?

评估了在鼻腔皮质激素(NC)治疗中加入透明质酸(HA)或正常盐水(NSS)作为附加疗法,与单独的NC治疗相比,在改善间歇性AR儿童的生活质量和减少鼻部症状评分方面的临床效果。

Allergol Immunopathol (Madr):过敏性鼻炎严重度与中性粒细胞/淋巴细胞、嗜酸性粒细胞/中性粒细胞和嗜酸性粒细胞/淋巴细胞比率的关系

调查了中性粒细胞与淋巴细胞比率(NLR)、嗜酸粒细胞与中性粒细胞比率(ENR)和嗜酸粒细胞与淋巴细胞比率(ELR)这三个炎症参数是否能够区分间歇过敏性鼻炎和持续过敏性鼻炎。

Am J Rhinol Allergy:鼻激发测试在过敏性鼻炎诊断中的作用

过敏性鼻炎(AR)是一种免疫球蛋白E(IgE)介导的鼻粘膜炎症性疾病,主要表现为反复流鼻涕、打喷嚏、鼻腔瘙痒和鼻塞。该疾病目前影响了全世界10%到40%的人口,严重影响患者的生活质量,并造成巨大的社会

Eur Arch Otorhinolaryngol:鼻腔细胞学方法诊断非过敏性鼻炎的表现如何?

鼻部病理可以通过症状学来表征,但难以区分过敏性鼻炎(AR)、非过敏性鼻炎(NAR)和慢性鼻窦炎(CRS)。鼻腔细胞学(NC)能够帮助临床医生区分鼻炎的各种亚型,其重要性日益增加。

J Asthma Allergy:SCIT+dupilumab治疗过敏性鼻炎是否优于单独的SCIT?

在SAR患者中,16周的SCIT+dupilumab能够改善SCIT的耐受性。

Clin Respir J:AR与NAR患者的血清瘦素差异及血清瘦素的诊断价值

比较了过敏性鼻炎(AR)和非过敏性鼻炎(NAR)患者的血清瘦素水平,并评估了瘦素的诊断价值情况。